Get Premium to unlock powerful stock data

Private Capital's 8 Largest Sales for the 2nd Quarter

Cabela's, Valeant among firm's divestitures

Author's Avatar
Aug 31, 2017
Article's Main Image

Private Capital (Trades, Portfolio)'s  Gregg Powers sold the following stocks during the second quarter:

The firm's Cabela's Inc. (

CAB, Financial) position was closed with an impact of -2.49% on the portfolio.

83ee60fdb6977bbb414a04e55f0fe497.png

The specialty retailer sells hunting, fishing and outdoor gear.

GuruFocus gives the company a profitability and growth rating of 7 out of 10. While the return on equity (ROE) of 6.68% is outperforming the sector, the return on assets (ROA) of 1.53% is underperforming 61% of companies in the Global Specialty Retail industry. Financial strength has a rating of 4 out of 10. The cash-debt ratio of 0.04 is below the industry median of 0.95.

The company's largest shareholder among the gurus is

Michael Price (Trades, Portfolio) with 0.75% of outstanding shares, followed by Mario Gabelli (Trades, Portfolio) with 0.32%, Jim Simons (Trades, Portfolio) with 0.17%, George Soros (Trades, Portfolio) with 0.03% and Murray Stahl (Trades, Portfolio) with 0.01%.

The firm exited its holding of Willis Towers Watson PLC (

WLTW, Financial). The trade had an impact of -1.32% on the portfolio.

13a012f2a255bf0609c09fae8c6fba39.png

The insurance broker designs and delivers solutions that manage risk, optimize benefits and expand the power of capital to protect institutions and individuals.

GuruFocus gives the company a profitability and growth rating of 7 out of 10. The ROE of 4.64% and ROA of 1.53% are underperforming 52% of companies in the Global Insurance Brokers industry. Financial strength has a rating of 5 out of 10. The cash-debt ratio of 0.20 is far below the industry median of 1,845.25.

Jeff Ubben (Trades, Portfolio) is the company's largest shareholder among the gurus with 4.92% of outstanding shares, followed by

David Herro (Trades, Portfolio) with 3.3%, First Eagle Investment (Trades, Portfolio) with 2.95%, Barrow, Hanley, Mewhinney & Strauss with 1.49% and Richard Pzena (Trades, Portfolio) with 0.99%.

The firm closed its American Public Education Inc. (

APEI, Financial) position, impacting the portfolio by -0.86%.

7a867030dda6cce4a98d66d0aab5a643.png

The company provides postsecondary education to individuals through online courses or classroom settings.

GuruFocus gives the company a profitability and growth rating of 7 out of 10. The ROE of 5.89% and ROA of 4.88% are outperforming 55% of companies in the Global Education and Training Services industry. Financial strength has a rating of 10 out of 10 with no debt.

With 5.18% of outstanding shares, Simons is the company's largest guru shareholder, followed by

Chuck Royce (Trades, Portfolio) with 0.71%, Barrow, Hanley, Mewhinney & Strauss with 0.47% and Paul Tudor Jones (Trades, Portfolio) with 0.07%.

The firm divested of its Valeant Pharmaceuticals International Inc. (

VRX, Financial) holding. The transaction had an impact of -0.82% on the portfolio.

4da9b6a39379868f968686c15d764e73.png

The specialty pharmaceutical and medical device company manufactures various treatments for the dermatology, gastrointestinal and ophthalmology markets.

GuruFocus gives the company a profitability and growth rating of 7 out of 10. The ROE of -27.72% and ROA of -2.56% are outperforming 84% of companies in the Global Drug Manufacturers - Specialty and Generic industry. Financial strength has a rating of 3 out of 10. The cash-debt ratio of 0.04 is below the industry median of 2.05.

The company's largest shareholder among the gurus is

Joel Greenblatt (Trades, Portfolio) with 0.24% of outstanding shares, followed by Ray Dalio (Trades, Portfolio) with 0.02%, Robert Bruce (Trades, Portfolio) with 0.17%, First Eagle Investment with 0.16%, Steven Cohen (Trades, Portfolio) with 0.01% and Diamond Hill Capital (Trades, Portfolio) with 0.01%.

The firm's Charter Financial Corp. (

CHFN, Financial) holding was reduced 20.48%. The transaction had an impact of -0.61% on the portfolio.

ce0271804177dce9a9fbf98d70178cbf.png

Charter Financial is the parent company of CharterBank, which offers banking services through its 15 branches in Georgia, Alabama and Florida.

GuruFocus gives the company a profitability and growth rating of 6 out of 10. While the ROE of 7.62% is underperforming the sector, the ROA of 1.08% is outperforming 56% of companies in the Global Banks - Regional - U.S. industry. Financial strength has a rating of 5 out of 10. The cash-debt ratio of 2.26 is above the industry median of 2.09.

With 6.19% of outstanding shares, Simons is the company's largest guru shareholder, followed by Private Capital with 5.18%.

The firm closed its position in Triumph Group Inc. (

TGI, Financial). The transaction had an impact of -0.46% on the portfolio.

527db579892a6fba1e027873ffba458d.png

The aerospace and defense company manufactures aerostructures, aircraft components and systems.

GuruFocus gives the company a profitability and growth rating of 7 out of 10. The ROE of -7.05% and ROA of -1.39% are outperforming 81% of companies in the Global Aerospace and Defense industry. Financial strength has a rating of 4 out of 10. The cash-debt ratio of 0.03 is below the industry median of 0.54.

The company's largest guru shareholder is

Richard Snow (Trades, Portfolio) with 1.58% of outstanding shares, followed by Simons with 0.78%, Greenblatt with 0.32% and Barrow, Hanley, Mewhinney & Strauss with 0.32%.

The firm reduced its holding of Celanese Corp. (

CE, Financial) by 13.42%. The trade had an impact of -0.35% on the portfolio.

fa58ea31e55de73c36af2e45e244c81f.png

The chemical company produces acetyl, cellulose derivatives and specialty polymers.

GuruFocus gives the company a profitability and growth rating of 5 out of 10. The ROE of 31.65% and ROA of 9.83% are outperforming 77% of companies in the Global Chemicals industry. Financial strength has a rating of 5 out of 10. The cash-debt ratio of 0.16 is below the industry median 0.76.

Dodge & Cox is the company's largest shareholder among the gurus with 8.55% of outstanding shares, followed by Barrow, Hanley, Mewhinney & Strauss with 1.38%, Pioneer Investments (Trades, Portfolio) with 0.59%,

Columbia Wanger (Trades, Portfolio) with 0.53%, Simons with 0.31% and Cohen with 0.19%.

The firm's Allergan PLC (

AGN, Financial) position was reduced by 2.48%, impacting the portfolio by -0.14%.

8b89c92be08f067cc53868a3cb8702b1.png

The pharmaceutical company develops and produces branded and generic drugs.

GuruFocus gives the company a profitability and growth rating of 6 out of 10. The ROE of 14.82% and ROA of 9.08% are outperforming 74% of the companies in the Global Drug Manufacturers - Specialty and Generic industry. Financial strength has a rating of 4 out of 10. The cash-debt ratio of 0.19 is below the industry median of 2.05.

The company's largest guru shareholder is the 

Vanguard Health Care Fund (Trades, Portfolio) with 3.42% of outstanding shares, followed by John Paulson (Trades, Portfolio) with 0.81%, David Tepper (Trades, Portfolio) with 0.75%, Seth Klarman (Trades, Portfolio) with 0.73%, Spiros Segalas (Trades, Portfolio) with 0.63%, John Griffin (Trades, Portfolio) with 0.43% and Pioneer Investments with 0.4%.

Disclosure: I do not own any shares of any stocks mentioned in this article.

Also check out:
Rating:
0 / 5 (0 votes)

GuruFocus Screeners

Related Articles